// App-Quantinova.ai

4457 : Chromatin remodeling as a potential new strategy for fusion positive rhabdomyosarcoma therapy

Researchers

Presenter

  • Joana G. Marques

Principal Investigators

  • Berkley Gryder

  • Maria Boehm

  • Marco Wachtel

  • Young Song

  • Hsien-Chao Chou

  • Rajesh Patidar

  • Hongling Liao

  • Javed Khan

  • Beat W. Schaefer

Medical Centers

  • University Childrens Hospital, Zurich, Switzerland

  • National Cancer Institute, Bethesda, MD

Locations

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Rhabdomyosarcoma

  • Solid malignancies

Biomarkers

  • Histone Deacetylase 2

  • Chromodomain-helicase-DNA-binding protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved